Atlantic City — The first case to go to trial over claims that Johnson & Johnson subsidiary McNeil Consumer Healthcare failed to give adequate warnings about the risks of taking high doses of Tylenol began Monday in New Jersey state court, in a woman’s suit alleging she suffered liver damage after taking the best-selling over the counter painkiller.
First Tylenol Liver Damage Trial Against J&J Begins In New Jersey
Posted by David Siegel on Sep 23, 2015 1:30:00 PM
Topics: Products Liability, Pharmaceutical, healthcare
Takeda Defends Diabetes Drug Actos At $2 Billion Product Liability Trial
Posted by David Siegel on Aug 31, 2015 12:03:00 PM
Topics: Products Liability, Pharmaceutical, Nevada
$2 Billion Suit Over Popular Diabetes Drug Actos' Alleged Cancer Risks Goes To Trial
Posted by David Siegel on Aug 27, 2015 6:25:00 PM
Plaintiffs' attorney Robert Eglet shows jurors the type of hard drives he claimed Takeda destroyed because they contained evidence that the widely-prescribed diabetes medication Actos causes bladder cancer. Click here to see video from the trial.
Topics: Products Liability, Pharmaceutical, Nevada
Opening Statement of the Week: D'Lesli Davis in Alsabagh v. Takeda
Posted by Arlin Crisco on Oct 27, 2014 10:41:00 AM
Topics: Products Liability, Pharmaceutical, Opening Statement of the Week, Trial Techniques, CVN National, Allen Alsabagh v. Takeda Pharmaceutical Industries
Retrial of Accutane Lawsuit Begins After $10.5 Million Verdict Reversed
Posted by David Siegel on Jan 30, 2014 4:00:39 PM
Atlantic City, NJ - Opening statements began today at a trial involving claims, that the widely prescribed acne medication Accutane caused inflammatory bowel disease, known as IBD, in a female plaintiff which led to the removal of her colon.
Topics: Kendall v. Roche, accutane, Pharmaceutical